Work

Cost to Medicare of Delayed Adalimumab Biosimilar Availability

Year: 2021

Type: article

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.2322

Authors: ChangWon C. Lee, Mehdi Najafzadeh, Aaron S. Kesselheim, Ameet Sarpatwari

Institutions: Brigham and Women's Hospital, Harvard University, Harvard–MIT Division of Health Sciences and Technology

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Arnold Ventures

OpenAlex ID: W3166396983

FWCI: 2.139

Cites: 14

Cited by: 18

Related to: 10